stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
Liberia-U.S. clinical ...
Initial study will evaluate experimental drug ...

NIH announces $41.5 million ...
Better understanding of the placenta promises to ...

NIBIB launches Want to Be a ...
Game introduces students to real-life examples of ...

Rare Disease Day at NIH to ...
Rare diseases affect an estimated 25 million ...

Data on children’s use of ...
Telebriefing and online presentation for members ...

Study finds peanut ...
NIH-funded trial compares consumption and ...

Molecule hijacks enzyme to ...
An experimental compound empowers an enzyme to ...

NIH-supported clinical trials ...
The trial will be conducted in South Africa, the ...

NIH-funded scientists create ...
New molecule also might prevent HIV infection.

NIH-sponsored HIV vaccine ...
Early-stage trial aims to build on RV144 results.

NIH expands key tuberculosis ...
wards over seven years will fund four ...

Eylea outperforms other drugs ...
Lucentis and Avastin perform similarly to Eylea ...

Stillbirth may increase ...
NIH-funded network study finds risk even for ...

NIH-supported researchers map ...
New maps of the human epigenome may further ...

NIH researchers reveal link ...
Findings point to potential drug targets.

NCCIH working group ...
Proposed research to focus on nondrug approaches ...

Nationwide study reports ...
Overall, natural products remain the most common ...

Nationwide survey reveals ...
More Americans of all ages are rolling out their ...

Study shows iron ...
About 25-35 percent of regular blood donors ...

2015 Avant-Garde Awards offer ...
NIH’s awards showcase potentially ...

NIH-funded research lays ...
New DARPA initiative builds on basic research.

Comprehensive new data on ...
NIH, NCCIH and CDC's NCHS will hold a ...

NIEHS funds six early-career ...
Award created to encourage early stage ...

Paramedics may be first line ...
NIH study demonstrates feasibility of getting ...